Interpretation of Chinese expert consensus on the whole-course management of hepatocellular carcinoma (2023 edition)

Yang Yang , Yu Yang , Juxian Sun , Shuqun Cheng , Qiu Li

Hepatoma Research ›› 2024, Vol. 10 : 5

PDF
Hepatoma Research ›› 2024, Vol. 10:5 DOI: 10.20517/2394-5079.2023.151
Editorial

Interpretation of Chinese expert consensus on the whole-course management of hepatocellular carcinoma (2023 edition)

Author information +
History +
PDF

Cite this article

Download citation ▾
Yang Yang, Yu Yang, Juxian Sun, Shuqun Cheng, Qiu Li. Interpretation of Chinese expert consensus on the whole-course management of hepatocellular carcinoma (2023 edition). Hepatoma Research, 2024, 10: 5 DOI:10.20517/2394-5079.2023.151

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Sung H,Siegel RL.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2021;71:209-49

[2]

World Health Organization. Global Cancer Observatory Home Page. Available from: https://gco.iarc.fr/ [Last accessed on 15 Jan 2024]

[3]

Yang JD,Gores GJ,Plymoth A.A global view of hepatocellular carcinoma: trends, risk, prevention and management.Nat Rev Gastroenterol Hepatol2019;16:589-604 PMCID:PMC6813818

[4]

Li Q.Chinese Association of Liver Cancer of Chinese Medical Doctor AssociationChinese expert consensus on the whole-course management of hepatocellular carcinoma (2023 edition).Chinese Journal of Digestive surgery2023;22:824-42

[5]

Elderkin J,Azmi AS.Hepatocellular carcinoma: surveillance, diagnosis, evaluation and management.Cancers2023;15:5118 PMCID:PMC10647678

[6]

Yao LQ,Yang T.ASO author reflections: α-fetoprotein in early-stage hepatocellular carcinoma (BCLC Stage 0/A): beyond diagnosis to prognostication.Ann Surg Oncol2024;31:1276-7

[7]

Deng Z,Han B.Early detection of hepatocellular carcinoma via no end-repair enzymatic methylation sequencing of cell-free DNA and pre-trained neural network.Genome Med2023;15:93 PMCID:PMC10631027

[8]

Shukla A,Sundaram S.Clinical profile, patterns of care & adherence to guidelines in patients with hepatocellular carcinoma: prospective multi-center study.J Clin Exp Hepatol2022;12:1463-73 PMCID:PMC9630010

[9]

Narayanan S,Cohen L.Medicinal mushroom supplements in cancer: a systematic review of clinical studies.Curr Oncol Rep2023;25:569-87.

[10]

Pesti-Asbóth G,Bíróné Molnár P.Monitoring physiological processes of fast-growing broilers during the whole life cycle: changes of redox-homeostasis effected to trassulfuration pathway predicting the development of non-alcoholic fatty liver disease.PLoS One2023;18:e0290310 PMCID:PMC10434899

[11]

Xu Y,Huang H.Establish a whole-process comprehensive surveillance management mode for immune checkpoint inhibitor pneumonitis.Zhonghua Yu Fang Yi Xue Za Zhi2023;57:1176-80

[12]

Black GB,Parker-Deeks S,Chung D.Using an electronic safety netting tool designed to improve safety with respect to cancer referral in primary care: a qualitative service evaluation using rapid appraisal methods.BMJ Open Qual2023;12:e002354 PMCID:PMC10373707

[13]

Cabibbo G,Borzio M.Multidisciplinary treatment of hepatocellular carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP), Italian Association of Hospital Gastroenterologists (AIGO), Italian Association of Radiology and Clinical Oncology (AIRO), Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP), Italian Society of Surgery (SIC), Italian Society of Gastroenterology (SIGE), Italian Society of Medical and Interventional Radiology (SIRM), Italian Organ Transplant Society (SITO), and Association of Patients with Hepatitis and Liver Disease (EpaC) - Part II - Non-surgical treatments.Dig Liver Dis2023;online ahead of print.

PDF

37

Accesses

0

Citation

Detail

Sections
Recommended

/